Teva Offers Drugs Valued at $23 Billion to End Opioid Suits - Bloomberg
U.S. charges Teva in generic drugs price-fixing probe
Teva: Warren Buffett Messed Things Up For Short-Sellers - Bloomberg
Teva Seeking to Break Its Streak of Post-Earnings Stock Losses - Bloomberg
Watch Teva to Make Fewer Generic Drugs - Bloomberg
Teva Rushes to Bring Malaria Drug to Coronavirus Patients - Bloomberg
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
Teva makes $40B offer for Mylan | The Arkansas Democrat-Gazette - Arkansas' Best News Source
Teva Loses CEO, Leaving Investors to Guess What's Next - Bloomberg
Teva considers sale of its active ingredients unit: Bloomberg - YouTube
Teva Wins Patent Case Related to Orexo Opioid-Treatment Drug - Bloomberg
Kare Schultz, president and chief executive officer of Teva... News Photo - Getty Images
Jana Partners Takes New Stake in Teva, Cheering Cost-Cut Plans - Bloomberg
Watch Teva CEO on Second-Quarter, Potential DOJ Settlement - Bloomberg
Teva (TEVA), AbbVie (ABBV) to Pay $161.5 Million in West Virginia Opioid Case - Bloomberg
Teva Lifts Outlook With Drug Production Mostly Unaffected by War - Bloomberg
Teva closes in on Allergan's generics unit
Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York state | CNN
Teva's CEO Was $2.8 Billion Down on His Second Day on the Job - Bloomberg
